A biotechnology company focused on developing therapeutic candidates derived from biological molecules, including programs historically aimed at oncology and other serious diseases. The business has operated primarily as a research and development organization with limited commercial revenue, relyin...
No congressional trades have been disclosed for Progen Corp Incorporated Com New (PCGN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.